In transfected HEK293-EBNA cells, Sildenafil dose dependently reduced the PDE6D/K-RasG12V-BRET signal, consistent with disruption of the complex, with EC50 = 11.4 μM. In purified ConA-stimulated CD4+ and CD8+ T cells, Sildenafil had no effect on proliferation compared with cultures without Sildenafil. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
BRET signal response in transfected cells
Cell-based study · HEK293-EBNA cells; n ≥ 3 [1]
Transfected HEK293-EBNA cells were treated with Sildenafil for 24 h, with DMSO as the vehicle control. Sildenafil dose dependently reduced the PDE6D/K-RasG12V-BRET signal, consistent with disruption of the complex, with EC50 = 11.4 μM.
Literature-Reported Treatment Conditions
- Treatment concentration
- between 320 and 0.018 μM
- Exposure duration
- Twenty-four hours after transfection, cells were treated for another 24 h
- Vehicle
- DMSO 0.1% v/v
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: Sildenafil
The paper names Sildenafil without stating the salt or form; not verified as the citrate form supplied as A10841. No dose conversion or lot validation.
Results > PDE6D Inhibitor Deltaflexin3 and Sildenafil Combine To Inhibit K-Ras Activity (S49); Materials and Methods > Bioluminescence Resonance Energy Transfer (BRET) Assay (S135, S140, S142); Materials and Methods > Synergy Analysis of Drug Combinations (S159); Figure 5 legend (S228)
PDE6D/K-RasG12V-BRET: PDE6D/K-RasG12V-BRET; comparator: DMSO 0.1% v/v as vehicle control — Results > PDE6D Inhibitor Deltaflexin3 and Sildenafil Combine To Inhibit K-Ras Activity (S49)
Proliferation of ConA-stimulated purified T cells
Cell-based study · CD4+ or CD8+ T cells [2]
Purified CD4+ and CD8+ T cells stimulated with ConA were cultured with or without 50 μg/ml Sildenafil for 3 d. Sildenafil had no effect on proliferation measured by thymidine incorporation.
Literature-Reported Treatment Conditions
- Treatment concentration
- 50 μg/ml
- Exposure duration
- 3 d
- Method
- added to the cell cultures
- Co-treatment
- Other interventions in this design: ConA. Compound effect isolated by the comparison: with or without 50 μg/ml sildenafil.
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Sildenafil
The paper names Sildenafil without stating the salt or form; not verified as the citrate form supplied as A10841. No dose conversion or lot validation.
RESULTS > In vitro sildenafil down-regulates the myeloid suppressor cell suppressive marker IL-4Rα (S66); MATERIALS AND METHODS > Drugs and cytokines. (S127); Figure 5. legend (S230, S232)
T cell proliferation was determined by [3H]thymidine incorporation: T cell proliferation was determined by [3H]thymidine incorporation; comparator: without 50 μg/ml sildenafil — RESULTS > In vitro sildenafil down-regulates the myeloid suppressor cell suppressive marker IL-4Rα (S66); Figure 5. legend (S232)